Biotech Values

[walldiver]

<<It’s really that simple, IMO, but simplicity probably doesn’t sell newsletters.>>

Wow. I bet you felt real good after letting that one go. Especially after you were deliberately provoked by the vicious personal attack on you quoted below:

"DNDN – If you know your BLA is rate-limited by a CMC section that won't be ready until Q4, why bother rushing the clinical section? What strategic or other value do you get by submitting the clinical section early given the FDA is already overwhelmed with filings?"

Dew--I too was shocked by the ferocity of this personal attack. I wish he would tone it down in these discussions.